FindMyKOL

Alfredo Clavell, MD

Basic profile

Mayo Clinic

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionRochester, MN · MidwestSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Alfredo Clavell is a Cardiology physician affiliated with Mayo Clinic. OpenAlex indexes 168 publications with 8,355 citations (h-index 34); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
168publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

8,355citations

Citations across these publications.

34h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Abbott Laboratories
    Program year20255 payments
    $523
  • Abbott Laboratories
    Program year20243 payments
    $337
  • Abbott Laboratories
    Program year20232 payments
    $220
All 6 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    57.8%
    Beta blocker12.7%
    Metoprolol Succinate57%Carvedilol43%
    Part D≥27 patients
    Loop diuretic10.1%
    Furosemide63%Torsemide37%
    Part D≥28 patients

    + 8 more classes in this area

  • Nervous system

    12.4%
    Other nervous system drugs9.4%
    Vyndamax74%Vyndaqel26%
    Part D<11 patients
    Gabapentinoids1.6%
    Gabapentin100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    10.8%
    SGLT2 inhibitor3.6%
    Farxiga64%Jardiance36%
    Part D<11 patients
    Potassium supplement2.7%
    Potassium Chloride100%
    Part D≥11 patients

    + 2 more classes in this area

Where care is delivered (Part B)35.8% facility · 64.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”